Analysis of early-stage tumours showed EphA3 was almost exclusively expressed in GFP+, CD90+/Sca1-high MSCs (Figure S3), and this population was significantly reduced in tumours from EphA3 shRNA host mice compared to control hosts (Figure 5A,B), suggesting reduced recruitment from the bone marrow. Here, EPHA3 is linked to neoplasm.